Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 24/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.72 USD | -1.43% |
|
-6.98% | -25.26% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -7.8x | - | -0.03x | - | - | - | - | 1B | |
| 33.31x | 4.45x | 1.25x | 5.98x | 17.9x | 25.05x | 0.97% | 48.01B | |
| 35.42x | 6.47x | -37x | 3.39x | 14.64x | 22.13x | -.--% | 45.27B | |
| 47.15x | 7.98x | 0.23x | 5.46x | 29.88x | 34.39x | -.--% | 40.93B | |
| -20.54x | 21.66x | -0.32x | 221.64x | -22.17x | -21.01x | -.--% | 42.84B | |
| 26.85x | 2.18x | 0.55x | 7.74x | 19.93x | 23.35x | 0.42% | 29.6B | |
| 35.29x | 25.32x | 2.34x | 5.79x | 26.32x | 27.53x | -.--% | 17.32B | |
| 25.91x | 2.88x | 0.75x | 2.22x | 9.63x | 14.93x | 1.03% | 15.34B | |
| -59.05x | 29.6x | 47.99x | 9.67x | 236.13x | -1795.63x | -.--% | 14.84B | |
| 87.43x | 4.67x | -0.41x | 4.14x | 16.03x | 19.69x | -.--% | 14.06B | |
| 29.52x | 1.4x | 0.29x | 1.93x | 11.89x | 13.54x | -.--% | 13.42B | |
| -423.67x | 2.77x | 4.45x | 13x | 77.2x | 101x | -.--% | 11.56B | |
| 52.52x | 4.58x | 2.75x | 8.72x | 24.74x | 29.51x | 0.44% | 11.38B | |
| 39.55x | 4.61x | 2.31x | 4.7x | 20.1x | 32.04x | 0.56% | 10.95B | |
| -29.91x | 8.69x | -6.06x | 79.29x | -19.89x | -19.33x | -.--% | 9.63B | |
| 23.24x | 2.45x | -20.27x | 4.62x | 12.42x | 15.83x | 0.3% | 9.22B | |
| 29.53x | - | -0.09x | 15.4x | 28.1x | 27.45x | -.--% | 8.89B | |
| -19.77x | 6.76x | 1.34x | 1643.26x | -21.04x | -21.43x | -.--% | 8.07B | |
| -20.28x | 7.01x | -6.64x | 8345.71x | -16.48x | -16.23x | -.--% | 7.87B | |
| Average | -6.07x | 8.44x | -0.35x | 576.82x | 25.85x | -82.62x | 0.21% | 18.96B | |
| Weighted average by Cap. | 7.78x | 9.08x | -2.83x | 253.13x | 22.68x | -56.58x | 0.25% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
